Author: Bill Snyder
Study explores how bacteria become drug resistant
Jan. 6, 2022—Vanderbilt researchers have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs.
Patient receives antibodies discovered at Vanderbilt to prevent COVID-19 illness
Dec. 23, 2021—On Dec. 22, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.
“Atlas” of lung development may aid efforts to heal premature lungs
Dec. 20, 2021—Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time.
Silver appointed to national committee assessing human requirements for energy intake and expenditure
Dec. 17, 2021—Vanderbilt's Heidi Silver, PhD, RDN, MS, has been appointed to an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine to assess the human requirements for energy intake and expenditure.
Two VUMC papers named among genomic medicine’s top 10
Dec. 16, 2021—Vanderbilt researchers wrote two of the “top 10” papers representing key advances in genomic medicine published between September 2020 and August 2021.
“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19
Dec. 10, 2021—Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.
VUMC expresses appreciation to NIH director Francis Collins on his retirement
Dec. 10, 2021—VUMC joins health leaders from across the country in applauding Francis Collins, M.D., Ph.D., for his 12-plus years of service as director of the National Institutes of Health. Collins, a physician-geneticist and the longest serving presidentially appointed NIH director, will retire at the end of the year. Since his appointment in August 2009, the annual...
Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization
Dec. 9, 2021—The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which protects against COVID-19, discovered last year at Vanderbilt University Medical Center.
Gene discoveries give new hope to people who stutter
Dec. 2, 2021—New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter.
VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit
Nov. 23, 2021—Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C.
Seven from VUMC among most highly cited researchers
Nov. 18, 2021—Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
The power of white matter
Nov. 11, 2021—Using a novel analysis of fMRI data, Vanderbilt researchers discovered intriguing patterns of signals in the brain’s white matter, the “conduit” for relaying signals between different brain regions.